S&P 500   4,668.31 (+1.60%)
DOW   35,236.11 (+0.96%)
QQQ   399.48 (+2.12%)
AAPL   160.66 (+2.46%)
MSFT   337.51 (+2.38%)
FB   338.44 (+1.60%)
GOOGL   2,902.95 (+2.08%)
AMZN   3,580.94 (+2.18%)
TSLA   1,133.89 (+4.80%)
NVDA   330.26 (+4.83%)
BABA   131.94 (-1.06%)
NIO   40.13 (+0.35%)
CGC   11.16 (-4.53%)
AMD   159.34 (+2.93%)
GE   98.04 (+0.20%)
MU   85.07 (+1.98%)
T   23.98 (-0.99%)
F   19.83 (+0.41%)
DIS   145.92 (-1.48%)
ACB   6.52 (-3.98%)
AMC   36.67 (-2.55%)
PFE   53.85 (-0.28%)
BA   197.81 (-0.70%)
S&P 500   4,668.31 (+1.60%)
DOW   35,236.11 (+0.96%)
QQQ   399.48 (+2.12%)
AAPL   160.66 (+2.46%)
MSFT   337.51 (+2.38%)
FB   338.44 (+1.60%)
GOOGL   2,902.95 (+2.08%)
AMZN   3,580.94 (+2.18%)
TSLA   1,133.89 (+4.80%)
NVDA   330.26 (+4.83%)
BABA   131.94 (-1.06%)
NIO   40.13 (+0.35%)
CGC   11.16 (-4.53%)
AMD   159.34 (+2.93%)
GE   98.04 (+0.20%)
MU   85.07 (+1.98%)
T   23.98 (-0.99%)
F   19.83 (+0.41%)
DIS   145.92 (-1.48%)
ACB   6.52 (-3.98%)
AMC   36.67 (-2.55%)
PFE   53.85 (-0.28%)
BA   197.81 (-0.70%)
S&P 500   4,668.31 (+1.60%)
DOW   35,236.11 (+0.96%)
QQQ   399.48 (+2.12%)
AAPL   160.66 (+2.46%)
MSFT   337.51 (+2.38%)
FB   338.44 (+1.60%)
GOOGL   2,902.95 (+2.08%)
AMZN   3,580.94 (+2.18%)
TSLA   1,133.89 (+4.80%)
NVDA   330.26 (+4.83%)
BABA   131.94 (-1.06%)
NIO   40.13 (+0.35%)
CGC   11.16 (-4.53%)
AMD   159.34 (+2.93%)
GE   98.04 (+0.20%)
MU   85.07 (+1.98%)
T   23.98 (-0.99%)
F   19.83 (+0.41%)
DIS   145.92 (-1.48%)
ACB   6.52 (-3.98%)
AMC   36.67 (-2.55%)
PFE   53.85 (-0.28%)
BA   197.81 (-0.70%)
S&P 500   4,668.31 (+1.60%)
DOW   35,236.11 (+0.96%)
QQQ   399.48 (+2.12%)
AAPL   160.66 (+2.46%)
MSFT   337.51 (+2.38%)
FB   338.44 (+1.60%)
GOOGL   2,902.95 (+2.08%)
AMZN   3,580.94 (+2.18%)
TSLA   1,133.89 (+4.80%)
NVDA   330.26 (+4.83%)
BABA   131.94 (-1.06%)
NIO   40.13 (+0.35%)
CGC   11.16 (-4.53%)
AMD   159.34 (+2.93%)
GE   98.04 (+0.20%)
MU   85.07 (+1.98%)
T   23.98 (-0.99%)
F   19.83 (+0.41%)
DIS   145.92 (-1.48%)
ACB   6.52 (-3.98%)
AMC   36.67 (-2.55%)
PFE   53.85 (-0.28%)
BA   197.81 (-0.70%)
BATS:BBRE

JPMorgan BetaBuilders MSCI US REIT ETF Stock Forecast, Price & News

$103.94
-3.34 (-3.11%)
(As of 11/26/2021 12:00 AM ET)
Add
Today's Range
$103.33
▼
$105.97
50-Day Range
$96.17
▼
$107.28
52-Week Range
N/A
Volume
6,475 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive BBRE News and Ratings via Email

Sign-up to receive the latest news and ratings for JPMorgan BetaBuilders MSCI US REIT ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer JPMorgan
Fund NameJPMorgan BetaBuilders MSCI US REIT ETF
Tax ClassificationRegulated Investment Company
SymbolBATS:BBRE
Inception Date6/15/2018
Fund ManagerNicholas DEramo, Michael Loeffler, Oliver Furby, Alex Hamilton
WebN/A
PhoneN/A

Fund Focus

Asset ClassReal Estate
BenchmarkMSCI US REIT Index
CategoryReal Estate
FocusReal Estate
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$1.45 billion
Average Daily Volume$40.52 thousand
Discount/Premium0.02%

ETF Expenses

Management Fee0.11%
Other Expenses0.00%
Total Expenses0.11%
Fee Waiver0.00%
Net Expenses0.11%

Administrator, Advisor and Custodian

AdministratorJ.P. Morgan Investment Management Inc.
AdvisorJ.P. Morgan Investment Management Inc.
CustodianJPMorgan Chase Bank, N.A.
DistributorJPMorgan Distribution Services, Inc.
Transfer AgentJPMorgan Chase Bank, N.A.
Trustee
Lead Market MakerCitadel

Geographic Exposure of BBRE

Currency Exposure of BBRE

Sector Exposure of BBRE

Industry Exposure of BBRE













JPMorgan BetaBuilders MSCI US REIT ETF (BATS:BBRE) Frequently Asked Questions

How has JPMorgan BetaBuilders MSCI US REIT ETF's stock been impacted by COVID-19 (Coronavirus)?

JPMorgan BetaBuilders MSCI US REIT ETF's stock was trading at $76.58 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, BBRE stock has increased by 35.7% and is now trading at $103.94.
View which stocks have been most impacted by COVID-19.

What other stocks do shareholders of JPMorgan BetaBuilders MSCI US REIT ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other JPMorgan BetaBuilders MSCI US REIT ETF investors own include Target (TGT), American Tower (AMT), AbbVie (ABBV), (AZN), Boeing (BA), Bristol-Myers Squibb (BMY), The Blackstone Group (BX), Clorox (CLX), salesforce.com (CRM) and Duke Energy (DUK).

What is JPMorgan BetaBuilders MSCI US REIT ETF's stock symbol?

JPMorgan BetaBuilders MSCI US REIT ETF trades on the BATS under the ticker symbol "BBRE."

Who are JPMorgan BetaBuilders MSCI US REIT ETF's major shareholders?

JPMorgan BetaBuilders MSCI US REIT ETF's stock is owned by a number of retail and institutional investors. Top institutional investors include Alaska Permanent Capital Management (0.00%), HighTower Advisors LLC (0.00%), University of Texas Texas AM Investment Managment Co. (0.00%), APCM Wealth Management for Individuals (0.00%), Morgan Stanley (0.00%) and Victory Capital Management Inc. (0.00%).

Which major investors are selling JPMorgan BetaBuilders MSCI US REIT ETF stock?

BBRE stock was sold by a variety of institutional investors in the last quarter, including Assetmark Inc., Alaska Permanent Capital Management, Massmutual Trust Co. FSB ADV, Advisor Group Holdings Inc., Morgan Stanley, GeoWealth Management LLC, and Sound Income Strategies LLC.

Which major investors are buying JPMorgan BetaBuilders MSCI US REIT ETF stock?

BBRE stock was purchased by a variety of institutional investors in the last quarter, including University of Texas Texas AM Investment Managment Co., Victory Capital Management Inc., HighTower Advisors LLC, Flow Traders U.S. LLC, APCM Wealth Management for Individuals, 55I LLC, and Royal Bank of Canada.

How do I buy shares of JPMorgan BetaBuilders MSCI US REIT ETF?

Shares of BBRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is JPMorgan BetaBuilders MSCI US REIT ETF's stock price today?

One share of BBRE stock can currently be purchased for approximately $103.94.


This page was last updated on 11/29/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.